Table 4 Diagnostic power of platelet count to discriminate patients with HCC from patients with cirrhosis in different three staging systems
Classification | AUC | Sens% | Spe% | PPV% | NPV% | AC% |
|---|---|---|---|---|---|---|
Number of nodules (n, %) | ||||||
Single (67, 43.2%) | 0.64 | 76 | 52 | 57 | 72 | 63 |
Multiple (88, 56.8) | 0.58 | 57 | 52 | 50 | 58 | 54 |
Macrovascular invasion (n, %) | ||||||
Absent (141, 91%) | 0.61 | 66 | 52 | 68 | 49 | 60 |
Present (14, 9%) | 0.66 | 75 | 52 | 17 | 94 | 54 |
Size of nodules (n, %) | ||||||
<2 (48, 31%) | 0.57 | 62 | 52 | 38 | 74 | 55 |
>2 (107, 69%) | 0.63 | 66 | 52 | 60 | 59 | 59 |
BCLC stage (n, %) | ||||||
0-A (109, 70.3%) | 0.61 | 67 | 52 | 63 | 56 | 60 |
B (46, 29.7) | 0.6 | 62 | 52 | 38 | 74 | 55 |
CLIP stage (n, %) | ||||||
0-1 (122, 79%) | 0.62 | 68 | 52 | 64 | 55 | 61 |
2-3 (33, 21%) | 0.6 | 60 | 52 | 34 | 76 | 55 |
Okuda stage (n, %) | ||||||
Stage I (117, 75.5%) | 0.65 | 71 | 52 | 65 | 59 | 63 |
Stage II (38, 24.5%) | 0.56 | 55 | 52 | 37 | 69 | 53 |